28 filings
8-K
IOBT
IO Biotech Inc
26 Apr 24
Departure of Directors or Certain Officers
5:26pm
8-K
IOBT
IO Biotech Inc
5 Mar 24
IO Biotech Announces 2023 Fourth-Quarter and Year-End Results
4:46pm
8-K
IOBT
IO Biotech Inc
8 Jan 24
Regulation FD Disclosure
8:11am
8-K
IOBT
IO Biotech Inc
13 Nov 23
IO Biotech Announces 2023 Third Quarter Results
8:10am
8-K
IOBT
IO Biotech Inc
11 Aug 23
IO Biotech Announces 2023 Second Quarter Results
8:31am
8-K
6zd3aobv51 9i8mb
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
8-K
dv8tqy508yilx 948
18 Jul 23
IO Biotech Strengthens Executive Management and US Presence with Appointment of Qasim Ahmad, MD, as Chief Medical Officer
4:05pm
8-K
8q8rl9t e4r8
14 Jun 23
IO Biotech Announces Achievement of Significant Phase 3 Clinical Trial Recruitment Milestone
8:06am
8-K
yxsqaz
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
vm1ia1 1pv
11 May 23
IO Biotech Announces 2023 First-Quarter Results
4:05pm
8-K
kstcmpzt2d
20 Apr 23
Departure of Directors or Certain Officers
4:10pm
8-K
hv6c5x1 ncmcten26o
14 Mar 23
IO Biotech Announces 2022 Fourth-Quarter and Year-End Results
4:18pm
8-K
lt6638
14 Mar 23
Results of Operations and Financial Condition
6:09am
8-K
f0wgcn
10 Mar 23
Regulation FD Disclosure
5:29pm
8-K
qzr1qd8 qz4o
15 Feb 23
Other Events
4:33pm
8-K
lwhbej2w4cr5nyhv 0r
9 Jan 23
Results of Operations and Financial Condition
8:01am
8-K
jtxw uvdbb7r
9 Nov 22
IO Biotech Announces Third Quarter Results for 2022
4:06pm
8-K
anws 013lym
13 Oct 22
IO Biotech Announces Appointment of New Chief Financial Officer
4:05pm
8-K
o4bqqcz cc76y2t
11 Aug 22
IO Biotech Announces Second Quarter Results for 2022
4:38pm
8-K
qon3b9cgvou5uh1sb5wt
26 May 22
Submission of Matters to a Vote of Security Holders
12:00am